BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 30575604)

  • 1. Ovarian Combined Low-grade Serous and Mesonephric-like Adenocarcinoma: Further Evidence for A Mullerian Origin of Mesonephric-like Adenocarcinoma.
    McCluggage WG; Vosmikova H; Laco J
    Int J Gynecol Pathol; 2020 Jan; 39(1):84-92. PubMed ID: 30575604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital Tract.
    Mirkovic J; McFarland M; Garcia E; Sholl LM; Lindeman N; MacConaill L; Dong F; Hirsch M; Nucci MR; Quick CM; Crum CP; McCluggage WG; Howitt BE
    Am J Surg Pathol; 2018 Feb; 42(2):227-233. PubMed ID: 28984674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extrauterine Mesonephric-like Neoplasms: Expanding the Morphologic Spectrum.
    Deolet E; Arora I; Van Dorpe J; Van der Meulen J; Desai S; Van Roy N; Kaur B; Van de Vijver K; McCluggage WG
    Am J Surg Pathol; 2022 Jan; 46(1):124-133. PubMed ID: 34183523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian Combined Serous Borderline Tumor/Low-grade Serous Carcinoma and Mesonephric-like Lesion: Report of 2 Cases With New Observations.
    Nilforoushan N; Liu L; Finkelman BS; Andersen J; Liu Y; James J; Hung CF; Wu TC; Vang R; Xing D
    Int J Gynecol Pathol; 2023 Mar; 42(2):182-191. PubMed ID: 35348533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian mesonephric-like adenocarcinoma arising in serous borderline tumor: a case report with complex morphological and molecular analysis.
    Dundr P; Gregová M; Němejcová K; Bártů M; Hájková N; Hojný J; Stružinská I; Fischerová D
    Diagn Pathol; 2020 Jul; 15(1):91. PubMed ID: 32693840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Ovarian Adenocarcinoma With Combined Low-grade Serous and Mesonephric Morphologies Suggests a Müllerian Origin for Some Mesonephric Carcinomas.
    Chapel DB; Joseph NM; Krausz T; Lastra RR
    Int J Gynecol Pathol; 2018 Sep; 37(5):448-459. PubMed ID: 28863071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparison of GATA3, TTF1, CD10, and Calretinin in Identifying Mesonephric and Mesonephric-like Carcinomas of the Gynecologic Tract.
    Pors J; Cheng A; Leo JM; Kinloch MA; Gilks B; Hoang L
    Am J Surg Pathol; 2018 Dec; 42(12):1596-1606. PubMed ID: 30148742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesonephric-like Differentiation of Ovarian Endometrioid and High-grade Serous Carcinomas: Clinicopathological and Molecular Characteristics Distinct from Those of Mesonephric-like Adenocarcinoma.
    Choi KH; Kim H; Bae GE; Lee SH; Woo HY; Kim HS
    Anticancer Res; 2021 Sep; 41(9):4587-4601. PubMed ID: 34475087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a Müllerian duct lineage: a case report.
    Yano M; Shintani D; Katoh T; Hamada M; Ito K; Kozawa E; Hasegawa K; Yasuda M
    Diagn Pathol; 2019 Jun; 14(1):54. PubMed ID: 31174566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesonephric Adenocarcinoma and Mesonephric-like Adenocarcinoma of the Urinary Tract.
    Xing D; Liang SX; Gao FF; Epstein JI
    Mod Pathol; 2023 Jan; 36(1):100031. PubMed ID: 36788068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Combined Morphologic and Molecular Approach to Retrospectively Identify KRAS-Mutated Mesonephric-like Adenocarcinomas of the Endometrium.
    Kolin DL; Costigan DC; Dong F; Nucci MR; Howitt BE
    Am J Surg Pathol; 2019 Mar; 43(3):389-398. PubMed ID: 30489318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KRAS-mutated Uterine Endometrioid Carcinoma With Extensive Surface Changes Resulting in Striking Morphologic Mimicry of an Ovarian Serous Borderline Tumor.
    Kir G; Olgun ZC; Gunel H; Ozen F; McCluggage WG
    Int J Gynecol Pathol; 2020 Nov; 39(6):573-577. PubMed ID: 31855953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-grade ovarian serous neoplasms (low-grade serous carcinoma and serous borderline tumor) associated with high-grade serous carcinoma or undifferentiated carcinoma: report of a series of cases of an unusual phenomenon.
    Boyd C; McCluggage WG
    Am J Surg Pathol; 2012 Mar; 36(3):368-75. PubMed ID: 22082603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma: a morphologic and molecular genetic analysis.
    Dehari R; Kurman RJ; Logani S; Shih IeM
    Am J Surg Pathol; 2007 Jul; 31(7):1007-12. PubMed ID: 17592266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesonephric-Like Carcinosarcoma of the Ovary Associated with Low-Grade Serous Carcinoma: A Case Report.
    d'Amati A; Pezzuto F; Serio G; Marzullo A; Fortarezza F; Lettini T; Cazzato G; Cormio G; Resta L
    Diagnostics (Basel); 2021 May; 11(5):. PubMed ID: 34063676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From morphology to methylome: epigenetic studies of Müllerian mesonephric-like adenocarcinoma reveal similarities to cervical mesonephric adenocarcinoma
    Lin LH; Howitt BE; Kolin DL
    J Pathol; 2024 Jun; 263(2):135-138. PubMed ID: 38593211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adenocarcinomas with mesonephric features in gynecologic tract: a clinicopathological analysis of seven cases].
    Liang Y; Ruan HJ; Wang WS; Yu MH; Chen XD; Zhang XF
    Zhonghua Bing Li Xue Za Zhi; 2021 Jul; 50(7):791-795. PubMed ID: 34405616
    [No Abstract]   [Full Text] [Related]  

  • 18. Mesonephric Adenocarcinoma of the Uterine Corpus: A Case Report and Diagnostic Pitfall.
    Kim SS; Nam JH; Kim GE; Choi YD; Choi C; Park CS
    Int J Surg Pathol; 2016 Apr; 24(2):153-8. PubMed ID: 26510860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic and Molecular Features of Paired Cases of Metachronous Ovarian Serous Borderline Tumor and Subsequent Serous Carcinoma.
    Chui MH; Xing D; Zeppernick F; Wang ZQ; Hannibal CG; Frederiksen K; Kjaer SK; Cope L; Kurman RJ; Shih IM; Wang TL; Vang R
    Am J Surg Pathol; 2019 Nov; 43(11):1462-1472. PubMed ID: 31343420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GATA3 Is a Sensitive and Specific Marker of Benign and Malignant Mesonephric Lesions in the Lower Female Genital Tract.
    Howitt BE; Emori MM; Drapkin R; Gaspar C; Barletta JA; Nucci MR; McCluggage WG; Oliva E; Hirsch MS
    Am J Surg Pathol; 2015 Oct; 39(10):1411-9. PubMed ID: 26135559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.